OHSU leadership on stage at AACR
Dozens of OHSU Knight Cancer Institute researchers commanded the spotlight at the American Association for Cancer Research Annual Meeting in Orlando, Florida. Lisa Coussens, Ph.D., who concluded...
Tag: surrogate endpoint
New questions about the tradeoffs in ‘accelerated’ cancer drug studies
Cancer clinical trials that use less-reliable shortcut endpoints save relatively little time, according to an analysis of 107 cancer drugs approved for 188 indications from 2006 to 2017. Image:...